The investment thesis and the soil for expected higher uranium prices is based on a growing supply and demand imbalance. This is what I already wrote about. An underinvested, not growing supply base is facing higher, maybe even way higher demand from existing as well as new nuclear reactors that are under construction. Today, I am discussing the biggest uranium project under development.
Continue reading
As many commodity prices – being economically sensitive resources – have dropped massively over the last months (and even more so over the last weeks) as well as a recession being expected by the consensus, the question is whether equities of commodity producers in general are about to crash. At least this was the procedure during the last Great Recession of 2008–2009. However, this is too simplified, completely ignoring history.
Continue reading
As I am publishing this Weekly, already a week has passed after the collapse of not just one bank dealing with startups – that was the 16th largest bank in the US – but indeed three banks. After emotions calmed down a bit, we can have a look at what went wrong and what you should be aware of. My Premium Members already knew about the risks “hidden” on the balance sheets of banks, as I’ve closed an investment case on a profit a month ago due to these risks. And no, this is not a buy-the-dip occasion!
Continue reading
Stocks of big pharmaceutical companies have been core holdings in many portfolios for as long as I can remember, probably even beyond that. The reasons are crystal-clear: an ever aging population, more chronic diseases also among younger generations, stable to slightly rising demand throughout the business cycle, relative price stability of those stocks and reliable dividends. What’s not to like?
Continue reading
Even though I know that I certainly won’t make many new friends with this article, especially not from the ranks of dividend investors, it is a duty for me to address this topic. I also think, it’s no coincidence that my most popular article to date has been about looming dividend cuts. Simply put, it’s too important to be ignored.
Continue reading